Laxmi Goldorna House Ltd (LGHL.NS)
INR 516.65
(-5.0%)
INR 516.65
(-5.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -86.34 Million | 52.61 Million | -153.44 Million | -22.39 Million | -50.45 Million |
| Net Income | 94.78 Million | 5.52 Million | 1.68 Million | 1.68 Million | 1.61 Million |
| Depreciation & Amortization | 1.79 Million | 1.71 Million | 1.12 Million | 268.42 Thousand | 193.14 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -226.64 Million | 22.63 Million | -173.52 Million | -43.08 Million | -69.65 Million |
| Other non-cash items | 43.72 Million | 22.73 Million | 17.32 Million | 18.85 Million | 17.49 Million |
| Investing Cash Flow | -81.44 Million | -10.95 Million | -18.52 Million | -101.47 Thousand | -101.47 Thousand |
| Investments in PPE | -545 Thousand | -1.56 Million | -8.62 Million | -544.36 Thousand | -101.47 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -80.9 Million | -10.95 Million | 8.52 Million | -101.47 Thousand | - |
| Financing Cash Flow | 168.17 Million | -47.28 Million | 180.21 Million | 24.87 Million | 51.01 Million |
| Debt repayment | -360.37 Million | -24.55 Million | -197.53 Million | -76.77 Million | -68.51 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 82.8 Million | - |
| Other Financing Activities | -192.2 Million | -22.73 Million | 17.32 Million | 18.85 Million | - |
| Accounts receivables | -348.31 Million | -28.83 Million | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | 815.15 Million | -268.99 Million | -549.71 Million | -134.93 Million | -63.97 Million |
| Other working capital | -693.48 Million | 320.47 Million | - | - | - |
| Cash at beginning of period | 6.95 Million | 12.58 Million | 4.34 Million | 1.96 Million | 1.5 Million |
| Cash at end of period | 7.34 Million | 6.95 Million | 12.58 Million | 4.34 Million | 1.96 Million |
| Capital Expenditure | -545 Thousand | -1.56 Million | -8.62 Million | -544.36 Thousand | -101.47 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 387.09 Thousand | -5.63 Million | 8.23 Million | 2.38 Million | 460.7 Thousand |
| Free Cash Flow | -86.88 Million | 51.04 Million | -162.07 Million | -22.93 Million | -50.55 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.7 Million | 54.52 Million | 57.34 Million | 20.37 Million | 5.52 Million | 3.68 Million |
| Depreciation & Amortization | - | - | - | - | 1.71 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | 22.63 Million | - |
| Other non-cash items | -11.7 Million | -54.52 Million | -57.34 Million | -20.37 Million | 22.73 Million | -3.68 Million |
| Investing Cash Flow | - | - | - | - | -10.95 Million | - |
| Investments in PPE | - | - | - | - | -1.56 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | -47.28 Million | - |
| Debt repayment | - | - | - | - | -24.55 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | -268.99 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | - | 12.58 Million | - |
| Cash at end of period | - | - | - | - | 6.95 Million | - |
| Capital Expenditure | - | - | - | - | -1.56 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | -5.63 Million | - |
| Free Cash Flow | - | - | - | - | 51.04 Million | - |
MEDICO
MDRNSTL
GALXBRG
MMRUBBR-B
BPTR
LEX